Back to search

University of British Columbia

Neuroprotective effect of sigma-1 receptor and activin A on synaptic function and calcium handling in Huntington disease

Abstract

dc:description

Huntington disease (HD) is a monogenic disorder with autosomal dominant inheritance. In HD patients, neurons in the striatum and cortex degenerate, leading to motor and cognitive disorders. Dysregulation of synaptic function and calcium handling is common in many neurodegenerative diseases. N-methyl-D-aspartate (NMDA) receptor function is enhanced at extrasynaptic sites, altering the balance of calcium-dependent neuronal survival vs. death signalling pathways. Another important level of calcium regulation is at the endoplasmic reticulum (ER), and this regulation is abnormal in HD. The ER is also suggested to be involved in nuclear calcium signalling, and I hypothesise that this signalling pathway is altered in HD. Sigma-1 receptors (S1Rs) – proteins located on the ER – play an important role in calcium regulation and thus gene transcription. Interestingly, activating S1Rs has been shown to normalise this ER calcium handling and restore synaptic function in HD mouse models. Furthermore, recent work has shown that overexpression of Activin A, a secreted protein whose transcription is nuclear-calcium-dependent, reduces toxic extrasynaptic NMDA receptor signalling in the hippocampus. The goal of this project is to determine the link between S1Rs, calcium handling, Activin A, and synaptic function to better understand the pathophysiological mechanisms of HD and to find new potential treatments. Neuronal cultures, imaging techniques, behavioural assessment, and electrophysiology were used to investigate these processes in a mouse model of HD. Our data shows contributions of different calcium channels to nuclear calcium signalling. Calcium imaging also suggests impairments in nuclear calcium signalling in HD striatal medium-sized spiny neurons in co-culture with cortical neurons, which was not corrected by treatment with S1R agonists. Furthermore, our data show that Activin A is decreased in HD culture media, and its overexpression normalises extrasynaptic NMDA receptor expression. Moreover, early injection of an Activin A AAV virus into the striatum led to a significant improvement in a motor coordination task at an age when HD mice are known to show impairment. This project has elucidated therapeutic benefits of Activin A in the treatment of HD; more research is needed to understand Activin A’s mechanism of action and further explore its potential benefits in other neurodegenerative diseases.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Neuroscience
Grantor dc:publisher
University of British Columbia
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Nassrallah, Wissam
Contributors dc:contributor
  • Raymond, Lynn A.

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/81803

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Nassrallah, Wissam. Neuroprotective effect of sigma-1 receptor and activin A on synaptic function and calcium handling in Huntington disease. doctoral thesis, University of British Columbia, 2022. http://hdl.handle.net/2429/81803